Prosight Management, LP - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$1,314,000
+83.5%
444,068
+128.1%
0.73%
+39.6%
Q2 2018$716,000
-12.3%
194,663
-16.5%
0.52%
+2.5%
Q1 2018$816,000
-11.8%
233,003
-21.4%
0.51%
-24.7%
Q4 2017$925,000296,4880.68%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,703,420$2,685,0002.61%
Healthcare Value Capital, LLC 1,400,000$1,015,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 581,042$421,0000.06%
KNOTT DAVID M 109,135$79,0000.03%
EdgePoint Investment Group Inc. 3,100,931$2,248,0000.02%
Yakira Capital Management, Inc. 36,428$26,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$33,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,353$61,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 19,814$14,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders